M
Minying Royston
Researcher at AstraZeneca
Publications - 2
Citations - 16
Minying Royston is an academic researcher from AstraZeneca. The author has contributed to research in topics: Neuromyelitis optica & Medicine. The author has co-authored 2 publications.
Papers
More filters
Journal ArticleDOI
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder.
Dean M. Wingerchuk,Ina Zhang,Adrian Kielhorn,Minying Royston,Michael J. Levy,Kazuo Fujihara,Ichiro Nakashima,Imran Tanvir,Friedemann Paul,Friedemann Paul,Sean J. Pittock +10 more
TL;DR: In this article, a network meta-analysis of all U.S. Food and Drug Administration-approved therapies (eculizumab, inebilizumaab, and satralizumaba) for adults with aquaporin-4 immunoglobulin G-positive (AQP4+) NMOSD was conducted via a systematic literature review (SLR) using data from randomized controlled trials (RCTs).
Journal ArticleDOI
Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis.
Robert Kadish,Stacey L. Clardy,Minying Royston,Imran Tanvir,Tavan Parker,Joseph Biskupiak,Adrian Kielhorn +6 more
TL;DR: In this paper, a retrospective, observational analysis of 47 patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD) enrolled at the University of Utah healthcare system was conducted.